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Background
Immunotherapy with mite allergens is effective both in
rhinitis and asthma. However, injection immunotherapy
carries a high risk of systemic adverse events, so, the
sublingual route (SLIT) is being used more frequently.
Efficacy of SLIT in asthma has been widely studied,
however, in Cuba, the therapeutic effect of mite vaccines
of Dermatophagoides pteronyssinus (Dp), D.siboney (Ds)
and Blomia tropicalis(Bt) has been demonstrated only in
adults, but not children. This aim is to determinate
adherence and tolerability of SLIT with mite allergen
vaccines using different treatment schedules in asth-
matic children.
Methods
One hundred and twenty children (2 to 15 years) with
mild to moderate asthma were selected for each treatment
schedule. Three dosing schedules were used: (1) maximum
of 3 daily drops; (2): max. 5 drops and (3) max. 10 drops,
all by sublingual route. Incremental updosing was used for
3 weeks. A maintenance dose of 2000 BU was used once a
week for schedule 1 and twice a week for schedules 2 and
3, during 2 months. Standardized House Dust Mite allergen
vaccines of Dermatophagoides pteronyssinus, D. siboney and
Blomia tropicaliswere employed (VALERGEN, BIOCEN,
Cuba).
Results
Adherence to treatment was above 90% for the three
schemes with no statistically significant difference
(p>0,08) among them. The patients tolerated the differ-
ent dosing schedules without having to change the
planned scheme. Only two patients reported local
adverse reactions, classified both as grade I (mild tongue
itching without medication).
Conclusions
Summarizing, all children tolerated the three schedules
similarly and adherence was high.
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